Mainz Biomed N.V.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYNZ and other ETFs, options, and stocks.About MYNZ
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions.
CEOGuido Baechler
CEOGuido Baechler
Employees26
Employees26
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2021
Founded2021
Employees26
Employees26
MYNZ Key Statistics
Market cap7.08M
Market cap7.08M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume117.57K
Average volume117.57K
High today$2.34
High today$2.34
Low today$1.96
Low today$1.96
Open price$2.21
Open price$2.21
Volume143.65K
Volume143.65K
52 Week high$40.40
52 Week high$40.40
52 Week low$1.96
52 Week low$1.96
People also own
Based on the portfolios of people who own MYNZ. This list is generated using Robinhood data, and it’s not a recommendation.